Biomarkers Market Size Worth USD 146.78 Billion by 2034 | CAGR: 9.84%

The biomarkers market size is expected to reach USD 146.78 Billion by 2034, according to a new study by Polaris Market Research. The report “Biomarkers Market Size, Share, Trends, & Industry Analysis By Type, (Safety Biomarkers, Efficacy Biomarkers, and Validation Biomarkers), By Research Area, By Technology, By Disease Indication, By Application, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global biomarkers market continues to expand due to its growing use across clinical diagnostics, pharmaceutical research, and health monitoring processes. Biomarkers such as proteins, genes, and metabolites assays serve as biological indicators to measure health status or disease presence. Samples such as blood, tissue, and urine are typically used in laboratory settings to analyze these indicators for medical or research purposes.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/biomarkers-market/request-for-sample

The adoption of biomarkers is increasing in general health assessments and advanced clinical evaluations across hospitals, diagnostic labs, and research centers. The role of biomarkers in improving clinical workflows and supporting more informed medical decisions continues to grow as laboratory methods become more refined and accessible.

Top of FormBiomarkers Market Report Highlights

• Based on research area, the genomics segment held the leading market position in 2024, primarily due to its extensive application in detecting genetic variations, assessing disease susceptibility, and enabling precision medicine approaches across therapeutic areas.
• In terms of technology, the next-generation sequencing technology is anticipated to experience the most rapid market expansion during the forecast period. This accelerated growth reflects NGS's unparalleled capacity for high-throughput genomic analysis, which facilitates comprehensive biomarker discovery  
• North America captured the largest share of the biomarkers market in 2024, a position supported by the region's concentration of innovative biopharmaceutical firms, advanced diagnostic laboratories, and substantial investments in precision medicine research and development initiatives.
• The Asia Pacific biomarkers market is forecast to demonstrate the highest growth rate during the projection period, driven by rapid improvements in healthcare infrastructure, increasing adoption of advanced diagnostic technologies, and expanding capabilities in biomedical research across emerging economies in the region.
• A few global key market players include Abbott Laboratories, Agilent Technologies, Inc., BioMérieux SA, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Guardant Health, Inc., Illumina, Inc., Merck KGaA, QIAGEN N.V., Revvity, Inc.

Polaris Market Research has segmented the market report on the basis of type, research area, technology, disease indication, application, and region:

By Type Outlook (Revenue, USD Billion, 2020–2034)

• Safety Biomarkers
• Efficacy Biomarkers
• Validation Biomarkers

By Research Area Outlook (Revenue, USD Billion, 2020–2034)

• Genomics
• Proteomics
• Metabolomics
• Other Research Areas

By Technology Outlook (Revenue, USD Billion, 2020–2034)

• Immunoassays
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Mass Spectrometry
• Chromatography
• Other Technologies

By Disease Indication Outlook (Revenue, USD Billion, 2020–2034)

• Cancer
• Infectious Disease
• Immunological Disorders
• Neurological Disorders
• Cardiovascular Disorders
• Other Disease Indications

By Application Outlook (Revenue, USD Billion, 2020–2034)

• Clinical Diagnostics
• Drug Discovery & Development
• Personalized Medicine
• Clinical Research
• Other Application

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America